Distinct cellular factors regulate the c-myb promoter through its E2F element

Molecular and Cellular Biology

Volumn 19, Issue 12, 1999, Pages 8442-8450

  Campanero, Miguel R ^a   Armstrong, Monica ^a   Flemington, Erik ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE CONTROL; GENE REPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; METHYLATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN INTERACTION;

ANIMALIA;

EID: 0033508430     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.12.8442     Document Type: Article

References (75)

1. Adams, P. D., and W. K. Kaelin. 1996. The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol. 208:79-93.
2. Alitalo, K., R. Winqvist, C. C. Lin, A. De La Chapelle, M. Schwab, and J. M. Bishop. 1984. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci. USA 81:4534-4538.
3. Allen, K. E., S. de la Luna, R. M. Kerkhoven, R. Bernards, and N. B. La Thangue. 1997. Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors. J. Cell Sci. 110:2819-2831.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. Short protocols in molecular biology. John Wiley & Sons, Inc., New York, N. Y.
5. Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317-4324.
6. Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
7. Campanero, M. R., and E. K. Flemington. 1997. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:2221-2226.
8. Campanero, M. R., and E. K. Flemington. Unpublished data.
9. Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208:32-61.
10. Cress, W. D., and J. R. Nevins. 1994. Interacting domains of E2F1, DP1, and the adenovirus E4 protein. J. Virol. 68:4213-4219.
11. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
12. Duronio, R. J., P. C. Bonnette, and P. H. O'Farrell. 1998. Mutations of the Drosophila dDP, dE2F, and cyclin E genes reveal distinct roles for the E2F-DP transcription factor and cyclin E during the S-phase transition. Mol. Cell. Biol. 18:141-151.
13. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
14. Dyson, N., M. Dembski, A. Fattaey, C. Ngwu, M. Ewen, and K. Helin. 1993. Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J. Virol. 67:7641-7647.
15. Erisman, M. D., P. G. Rothberg, R. E. Diehl, C. C. Morse, J. M. Spandorfer, and S. M. Astrin. 1985. Deregulation of the c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol. Cell. Biol. 5:1969-1976.
16. Escot, C., C. Theillet, R. Lidereau, F. Spyratos, M. H. Champeme, J. Gest, and R. Callahan. 1986. Genetic alterations of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA 83:4834-4838.
17. Fagan, R., K. J. Flint, and N. Jones. 1994. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 KDa protein. Cell 78:799-811.
18. Field, S. J., F.-Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin, D. M. Livingston, S. H. Orkin, and M. E. Greenberg. 1996. E2F1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-561.
19. Flemington, E. K., S. H. Speck, and W. G. Kaelin. 1993. E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914-6918.
20. Foss, K., and W. H. McClain. 1987. Rapid site-directed mutagenesis in plasmids. Gene 59:285-290.
21. Griffin, C. A., and S. B. Baylin. 1985. Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res. 45:272-275.
22. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
23. Helin, K., E. Harlow, and A. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13: 6501-6508.
24. Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7:1850-1861.
25. Hiyama, H., A. Iavarone, and S. A. Reeves. 1998. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16:1513-1523.
26. Hofferer, M., C. Wirbelauer, B. Humar, and W. Krek. 1999. Increased levels of E2F-1-dependent DNA binding activity after UV- or γ-irradiation. Nucleic Acids Res. 27:491-4195.
27. Hsiao, K.-M., S. L. McMahon, and P. J. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526-1537.
28. Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514-1525.
29. Johnson, D. G., and R. Schneider-Broussard. 1998. Role of E2F in cell cycle control and cancer. Front. Biosci. 3:447-458.
30. Karlseder, J., H. Rotheneder, and E. Wintersberger. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell. Biol. 16:1659-1667.
31. Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557-1560.
32. Krek, W., G. Xu, and D. M. Livingston. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158.
33. Kumar, A. P., and A. P. Butler. 1998. Serum responsive gene expression mediated by Sp1. Biochem. Biophys. Res. Commun. 252:517-523.
34. Lam, E. W.-F., J. D. Bennett, and R. J. Watson. 1995. Cell-cycle regulation of human B-myb transcription. Gene 160:277-281.
35. Lam, E. W.-F., and R. J. Watson. 1993. An E2F-binding sites mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705-2713.
36. La Thangue, N. B. 1996. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 24:54-59.
37. Leone, G., J. DeGregori, Z. Yan, L. Jakoi, S. Ishida, R. S. Williams, and J. R. Nevins. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120-2130.
38. Liu, N., F. C. Lucibello, K. Engeland, and R. Muller. 1998. A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F. Oncogene 16:2957-2963.
39. Liu, N., F. C. Lucibello, K. Korner, L. A. Wolfraim, J. Zwicker, and R. Muller. 1997. CDF-1, a novel E2F-unrelated factor, interacts with cell cycle-regulated represser elements in multiple promoters. Nucleic Acids Res. 25:4915-4920.
40. Luo, R. X., A. A. Postigo, and D. C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
41. Luscher, B., and R. N. Eisenman. 1990. New light on Myc and Myb. Part II. Myb. Genes Dev. 4:2235-2241.
42. MacGregor, G. R., and C. T. Caskey. 1989. Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res. 17:2365.
43. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
44. Muller, R. 1995. Transcriptional regulation during the mammalian cell cycle. Trends Genet. 11:173-178.
45. Mulligan, G., and T. Jacks. 1998. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14:223-229.
46. Neuman, E., E. K. Flemington, W. R. Sellers, and W. G. Kaelin. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14:6607-6615.
47. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585-593.
48. Nicolaides, N. C., R. Gualdi, C. Casadevall, L. Manzella, and B. Calabretta. 1991. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol. Cell. Biol. 11:6166-6176.
49. Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146-12150.
50. Ormondroyd, E., S. de la Luna, and N. B. La Thangue. 1995. A new member of the DP family, DP3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene 11:1437-1446.
51. Pelicci, P. G., L. Lanfrancone, M. D. Brathwaite, S. R. Wolman, and R. Dalla-Favera. 1984. Amplification of the c-myb oncogene in a case of human acute myelomonocytic leukemia. Science 224:1117-1121.
52. Qin, X., T. Chittenden, D. M. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
53. Rogers, K. T., P. D. R. Higgins, M. M. Milla, R. S. Phillips, and J. M. Horowitz. 1995. DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Proc. Natl. Acad. Sci. USA 92:7594-7599.
54. Sala, A., N. C. Nicolaides, A. Engelhard, T. Bellon, D. C. Lawe, A. Arnold, X. Graña, A. Giordano, and B. Calabretta. 1994. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res. 54:1402-1406.
55. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
56. Sardet, C., L. LeCam, E. Fabbrizio, and M. Vidal. 1997. E2Fs and the retinoblastoma protein family, p. 1-63. in J. Ghysdael and M. Yaniv (ed.), Oncogenes as transcriptional regulators. Birkhauser Verlag, Berlin, Germany.
57. Schulze, A., K. Zerfass, S. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Durr, and B. Henglein. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92:11264-11268.
58. Sears, R., K. Ohtani, and J. R. Nevins. 1997. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell. Biol. 17:5227-5235.
59. Sellers, W. R., J. W. Rodgers, and W. G. Kaelin. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544-11548.
60. Shan, B., X. Zhu, P.-L. Chen, T. Durfee, Y. Yang, D. Sharp, and W.-H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factors E2F. Mol. Cell. Biol. 12:5620-5631.
61. Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2f interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell 68:157-166.
62. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154-158.
63. Slamon, D. J., T. C. Boone, D. C. Murdock, D. E. Keith, M. F. Press, R. A. Larson, and L. M. Souza. 1986. Studies of the human c-myb gene and its product in human acute leukemias. Science 233:347-351.
64. Slamon, D. J., J. B. DeKernion, I. M. Verma, and M. J. Cline. 1984. Expression of cellular oncogenes in human malignancies. Science 224:256-262.
65. Slansky, J. E., and P. J. Farnham. 1996. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208: 1-30.
66. Stern, J. B., and K. A. Smith. 1986. Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science 233:203-206.
67. Thiele, C. J., P. S. Cohen, and M. A. Israel. 1988. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol. Cell. Biol. 8:1677-1683.
68. Thiele, C. J., C. McKeon, T. J. Triche, R. A. Ross, C. P. Reynolds, and M. A. Israel. 1987. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J. Clin. Investig. 80:804-811.
69. Thompson, C. B., P. B. Challoner, P. E. Neiman, and M. Groudine. 1986. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 319:374-380.
70. Weintraub, S. J., K. N. B. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active repression by the retinoblastoma protein. Nature 375:812-815.
71. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
72. Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N. J. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F1. Cell 85: 537-548.
73. Yan, Z., J. DeGregori, R. Shohet, G. Leone, B. Stillman, J. R. Nevins, and R. S. Williams. 1998. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc. Natl. Acad. Sci. USA 95:3603-3608.
74. Yokota, J., Y. Tsunetsugu-Yokota, H. Bultifora, C. L. Fevre, and M. J. Cline. 1986. Alterations of the myc, myb and Ha-ras proto-oncogenes in cancers are frequent and show clinical correlations. Science 231:261-265.
75. Zhu, L., L. Zhu, E. Xie, and L.-S. Chang. 1995. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol. Cell. Biol. 15:3552-3562.